Literature DB >> 9603968

Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors.

H von der Kammer1, M Mayhaus, C Albrecht, J Enderich, M Wegner, R M Nitsch.   

Abstract

In order to search for genes that are activated by muscarinic acetylcholine receptors (mAChRs), we used an mRNA differential display approach in HEK293 cells expressing m1AChR. The zinc-finger transcription factor genes Egr-1, Egr-2, and Egr-3 were identified. Northern blot analyses confirmed that mRNA levels of Egr-1, Egr-2, and Egr-3 increased readily after m1AChR stimulation and that a maximum was attained within 50 min. At that time, Egr-4 mRNA was also detectable. Western blots and electromobility shift assays demonstrated synthesis of EGR-1 and EGR-3, as well as binding to DNA recognition sites in response to m1AChR activation. Activation of m1AChR increased transcription from EGR-dependent promoters, including the acetylcholinesterase gene promoter. Activity-dependent regulation of Egr-1 mRNA expression and EGR-1 protein synthesis was also observed in cells expressing m2, m3, or m4AChR subtypes. Increased EGR-1 synthesis was mimicked by phorbol myristate acetate, but not by forskolin, and receptor-stimulated EGR-1 synthesis was partially inhibited by phorbol myristate acetate down-regulation. Together, our results demonstrate that muscarinic receptor signaling activates the EGR transcription factor family and that PKC may be involved in intracellular signaling. The data suggest that transcription of EGR-dependent target genes, including the AChE gene, can be under the control of extracellular and intracellular signals coupled to muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603968     DOI: 10.1074/jbc.273.23.14538

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Long-term cholinesterase inhibitor treatment of Alzheimer's disease.

Authors:  Peter Johannsen
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

Authors:  Harald Hampel; Richard Frank; Karl Broich; Stefan J Teipel; Russell G Katz; John Hardy; Karl Herholz; Arun L W Bokde; Frank Jessen; Yvonne C Hoessler; Wendy R Sanhai; Henrik Zetterberg; Janet Woodcock; Kaj Blennow
Journal:  Nat Rev Drug Discov       Date:  2010-07       Impact factor: 84.694

3.  EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.

Authors:  Joerg Kumbrink; Kathrin H Kirsch; Judith P Johnson
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 4.  Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

Authors:  A Nordberg; A L Svensson
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

5.  Ovulation requires the activation on proestrus of M₁ muscarinic receptors in the left ovary.

Authors:  M E Cruz; A Flores; B E Alvarado; C G Hernández; A Zárate; R Chavira; M Cárdenas; I Arrieta-Cruz; R Gutiérrez-Juárez
Journal:  Endocrine       Date:  2015-01-14       Impact factor: 3.633

Review 6.  Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?

Authors:  E Giacobini
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress.

Authors:  I Greeve; I Hermans-Borgmeyer; C Brellinger; D Kasper; T Gomez-Isla; C Behl; B Levkau; R M Nitsch
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

Review 8.  Dopaminergic system in birdsong learning and maintenance.

Authors:  Lubica Kubikova; Lubor Kostál
Journal:  J Chem Neuroanat       Date:  2009-11-10       Impact factor: 3.052

9.  Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.

Authors:  Marie M Svedberg; Anne-Lie Svensson; Mary Johnson; Mandy Lee; Osnat Cohen; Jennifer Court; Hermona Soreq; Elaine Perry; Agneta Nordberg
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

10.  Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia.

Authors:  Kazuo Yamada; David J Gerber; Yoshimi Iwayama; Tetsuo Ohnishi; Hisako Ohba; Tomoko Toyota; Jun Aruga; Yoshio Minabe; Susumu Tonegawa; Takeo Yoshikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.